AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
1.390
-0.160 (-10.32%)
At close: Dec 2, 2025, 4:00 PM EST
1.390
0.00 (0.00%)
After-hours: Dec 2, 2025, 4:10 PM EST
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of $3.97 million as of December 2, 2025. Its market cap has decreased by -71.26% in one year.
Market Cap
3.97M
Enterprise Value
3.99M
1-Year Change
-71.26%
Ranking
n/a
Category
Stock Price
$1.39
Market Cap Chart
Since December 1, 1998, AIM ImmunoTech's market cap has decreased from $159.10M to $3.97M, a decrease of -97.51%. That is a compound annual growth rate of -12.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 4.40M | -65.08% |
| Dec 31, 2024 | 12.60M | -41.40% |
| Dec 29, 2023 | 21.50M | 43.33% |
| Dec 30, 2022 | 15.00M | -65.91% |
| Dec 31, 2021 | 44.00M | -39.56% |
| Dec 31, 2020 | 72.80M | 1,517.78% |
| Dec 31, 2019 | 4.50M | -48.28% |
| Dec 31, 2018 | 8.70M | -20.91% |
| Dec 29, 2017 | 11.00M | -33.73% |
| Dec 30, 2016 | 16.60M | -16.58% |
| Dec 31, 2015 | 19.90M | -60.20% |
| Dec 31, 2014 | 50.00M | 12.61% |
| Dec 31, 2013 | 44.40M | 17.15% |
| Dec 31, 2012 | 37.90M | 43.02% |
| Dec 30, 2011 | 26.50M | -60.27% |
| Dec 31, 2010 | 66.70M | -10.23% |
| Dec 31, 2009 | 74.30M | 166.31% |
| Dec 31, 2008 | 27.90M | -50.09% |
| Dec 31, 2007 | 55.90M | -60.04% |
| Dec 29, 2006 | 139.90M | 19.27% |
| Dec 30, 2005 | 117.30M | 24.79% |
| Dec 31, 2004 | 94.00M | 10.33% |
| Dec 31, 2003 | 85.20M | 24.56% |
| Dec 31, 2002 | 68.40M | -50.18% |
| Dec 31, 2001 | 137.30M | -2.21% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |